These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19010861)

  • 21. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
    Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H
    Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
    Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; Carey LA; Grundy PE; Perlman EJ; Breslow NE; Sukumar S
    Cancer Res; 1999 Sep; 59(17):4301-7. PubMed ID: 10485476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
    Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
    Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer.
    Dasí F; Martínez-Rodes P; March JA; Santamaría J; Martínez-Javaloyas JM; Gil M; Aliño SF
    Ann N Y Acad Sci; 2006 Sep; 1075():204-10. PubMed ID: 17108213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
    Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
    Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
    Gertler R; Doll D; Maak M; Feith M; Rosenberg R
    Cancer; 2008 May; 112(10):2173-80. PubMed ID: 18348304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues.
    Li W; Li L; Liu Z; Liu C; Liu Z; Strååt K; Björkholm M; Jia J; Xu D
    Cancer Lett; 2008 Feb; 260(1-2):28-36. PubMed ID: 18037230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer].
    Li LR; Wan DS; Pan ZZ; Hardingham J; Rieger N; Hewett P; Zhou ZW; Chen G
    Ai Zheng; 2004 Nov; 23(11 Suppl):1502-7. PubMed ID: 15566667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
    Shen C; Hu L; Xia L; Li Y
    Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
    Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients.
    March-Villalba JA; Martínez-Jabaloyas JM; Herrero MJ; Santamaría J; Aliño SF; Dasí F
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S69-77. PubMed ID: 22559196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomerase RNA as a detection marker in the serum of breast cancer patients.
    Chen XQ; Bonnefoi H; Pelte MF; Lyautey J; Lederrey C; Movarekhi S; Schaeffer P; Mulcahy HE; Meyer P; Stroun M; Anker P
    Clin Cancer Res; 2000 Oct; 6(10):3823-6. PubMed ID: 11051224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
    Novakovic S; Hocevar M; Zgajnar J; Besic N; Stegel V
    Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
    de Kok JB; Verhaegh GW; Roelofs RW; Hessels D; Kiemeney LA; Aalders TW; Swinkels DW; Schalken JA
    Cancer Res; 2002 May; 62(9):2695-8. PubMed ID: 11980670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
    Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
    Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.